ArticleMolecular vision2025
Prevention of diabetic retinopathy in a rat model by a functional food mix.
Article in Molecular vision, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Diabetic retinopathy (DR), a severe microvascular complication of both type 1 and type 2 diabetes, is one of the leading causes of blindness. Prolonged hyperglycemia leads to vascular endothelial changes, inflammation, neovascularization, and apoptosis through multiple mechanisms, including increased aldose reductase (AR) activity and formation of advanced glycation end products, which contribute to the development of DR. Based on our previous studies with various functional foods that showed AR inhibition and prevented the formation of advanced glycation end products, in this study, a functional food (FF) mix was formulated and investigated its efficacy against DR progression in a rat model. Methods: An FF mix was prepared with powders of amla pericarp, turmeric rhizome, ginger rhizome, cinnamon bark, and black pepper seeds in a specific proportion. Two-month-old Sprague-Dawley rats were grouped into control (C), streptozotocin-induced diabetes (D), and diabetes fed with FF at two levels (FF1, 0.85 g/100 g diet; FF2, 4.25 g/100 g diet) for 6 months from the induction of diabetes. At the end of the experiment, electroretinography was performed, and the eyes were dissected after the animals were sacrificed. A set of eyes was formalin-fixed for histology and immunohistochemistry examination, and the retina from the remaining eyes was used for immunoblotting analysis. Results: Supplementation of FF mix in the diet to diabetic rats has improved retinal function (electroretinography), as well as prevented histomorphological changes and loss of photoreceptor cells (rhodopsin), compared to untreated diabetic rats. Further, FF mix ameliorated hyperglycemia-induced angiogenesis (vascular endothelial growth factor, hypoxia-inducible factor 1α) and gliosis (glial fibrillary acidic protein) in the diabetic rats, accompanied by decreased inflammation (phosphorylated nuclear factor κB, tumor necrosis factor α, monocyte chemoattractant protein 1) and apoptosis (Bax, Bcl2, caspase3, and caspase12). Conclusions: This study illustrates the potential of an FF mix, attributed to the synergistic effects of its components, alleviating the progression of diabetic retinopathy by reducing diabetes-induced hypoxia, gliosis, and inflammation, while also inhibiting apoptosis in retinal cells.
Indexed as
Identifiers
41867376PMC13002552What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.